India, March 3 -- All that was discussed in the House through the day

At present, the import of raw materials such as bulk drugs / active pharmaceutical ingredients (APIs) from China for preparing medicines has not stopped due to the novel coronavirus (COVID-19) outbreak, and India has sufficient stock of medicines, Union Minister of Chemicals and Fertilizers, DV Sadananda Gowda, said in response to a question in Lok Sabha on March 3, 2020.

He added that if the outbreak continued to disrupt manufacturing of APIs in China, then their supplies might be disrupted.

The Department of Pharmaceuticals has constituted a Committee under the chairmanship of Eshwara Reddy, joint drugs controller, Central Drugs Standard Control Organization to add...